Loading…
Eckert & Ziegler AG and TCL Healthcare Equipment (Shanghai) Co., Ltd. formed a joint venture, TCL Eckert & Ziegler BEBIG Healthcare (Wuxi) Co. Ltd., to develop, produce and distribute advanced tumor irradiation devices in China. The JV is held 49% by EZAG and 51% by TCL.
TCL Healthcare Equipment (Shanghai) and Eckert & Ziegler BEBIG signed a joint venture agreement to develop, manufacture, and distribute HDR afterloaders for brachytherapy in China. The JV, TCL Eckert & Ziegler BEBIG Healthcare (Wuxi), is 51% owned by TCL and 49% by Eckert & Ziegler.